ConductScience.org, home

Paper31300518

miRNAs and NAFLD: from pathophysiology to therapy.

Gjorgjieva M and 4 others. Gut, 2019. Cited by 206 papers, by iCite.

Cite this record

ConductScience Library. miRNAs and NAFLD: from pathophysiology to therapy. Papers, record 31300518. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31300518

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miRNAs and NAFLD: from pathophysiology to therapy.
PubMed
Journal
Gut
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
206
iCite
Relative citation ratio, by iCite
9.17
iCite
Revised in PubMed
2019-10-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gjorgjieva MMonika
2Sobolewski CCyril
3Dolicka DDobrochna
4Correia de Sousa MMarta
5Foti MMichelangelohttps://orcid.org/0000-0001-7199-4135

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Non-alcoholic Fatty Liver DiseaseMajor topic
Humans

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04861571Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLDBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by147

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.

PMIDTitleJournalYearIn PapersSource
42873313miR-142-3p overexpression targets CLTA and impairs clathrin-mediated endocytosis in HLSECs induced by high glucose.Acta Diabetol2026https://conductscience.org/library/papers/42873313PubMed
42783602Altered miRNA Expression Due to Bisphenol A Exposure and Associated Health Implications: A Narrative Review.J Xenobiot2026https://conductscience.org/library/papers/42783602PubMed
42589269MicroRNA-34a Promotes Hepatic Lipid Accumulation Through RXRα Suppression and Is Reversed by 9-cis-Retinoic Acid in Steatotic Hepatocytes.Int J Mol Sci2026https://conductscience.org/library/papers/42589269PubMed
42350562Systematic assessment for potential endogenous normalizers for microRNA analysis in fecal samples.Sci Rep2026https://conductscience.org/library/papers/42350562PubMed
42197305miR-27a Suppresses Mitochondrial Function to Promote Hepatic Steatosis in High-Fat-Diet-Induced Obesity.Molecules2026https://conductscience.org/library/papers/42197305PubMed
42138207Hepatic p38γ exacerbates acetaminophen‑induced acute liver injury via PI3K/Akt‑dependent mechanisms.Int J Mol Med2026https://conductscience.org/library/papers/42138207PubMed
42072626Hair Follicles as Micro-Organs: MicroRNA-Mediated Control of Growth, Cycling, and Fiber Traits.Biomolecules2026https://conductscience.org/library/papers/42072626PubMed
41621836RNA-Based Therapies for Inherited Metabolic Disorders.J Inherit Metab Dis2026https://conductscience.org/library/papers/41621836PubMed
41609940LncRNA TUG1 promotes hepatic lipid accumulation by targeting the miR-29a-3p/SREBP-2/HMGCR axis in MAFLD.Funct Integr Genomics2026https://conductscience.org/library/papers/41609940PubMed
41466504The Therapeutic Effect and Mechanism of Lactobacillus gardneri on Nonalcoholic Fatty Liver Disease.J Microbiol Biotechnol2025https://conductscience.org/library/papers/41466504PubMed
41456859MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD.Clin Mol Hepatol2026https://conductscience.org/library/papers/41456859PubMed
41226441miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future.Int J Mol Sci2025https://conductscience.org/library/papers/41226441PubMed
41104870Metabolic dysfunction‑associated steatotic liver disease: Pathogenesis, model and treatment (Review).Int J Mol Med2025https://conductscience.org/library/papers/41104870PubMed
40980810MicroRNA-18a-5p regulates hepatic lipid accumulation in response to high-fat diet.Front Physiol2025https://conductscience.org/library/papers/40980810PubMed
40943552MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression.Int J Mol Sci2025https://conductscience.org/library/papers/40943552PubMed
40901588Copper and hepatic lipid dysregulation: Mechanisms and implications.World J Hepatol2025https://conductscience.org/library/papers/40901588PubMed
40862638microRNAs Regulate Cellular Magnesium by Tuning Expression of the Plasma Membrane Protein CNNM4.ACS Chem Biol2025https://conductscience.org/library/papers/40862638PubMed
40720724E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p.Hepatology2026https://conductscience.org/library/papers/40720724PubMed
40682843Protective effect of exercise on metabolic dysfunction‑associated fatty liver disease: Potential epigenetic mechanisms (Review).Int J Mol Med2025https://conductscience.org/library/papers/40682843PubMed
40668532The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD.J Physiol Biochem2025https://conductscience.org/library/papers/40668532PubMed

See all 147 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31300518

GET https://conductscience.org/api/papers/v1/31300518/cited_by?page=2